CalciMedica, Common Correlations

CALC Stock

2.78 0.03 1.07%

The current 90-days correlation between CalciMedica, Common Stock and Lipocine is -0.13 (i.e., Good diversification). The correlation of CalciMedica, Common is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

CalciMedica, Common Correlation With Market

Average diversification

The correlation between CalciMedica, Common Stock and DJI is 0.15 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CalciMedica, Common Stock and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CalciMedica, Common Stock. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Moving together with CalciMedica, Stock

0.83	VALN	Valneva SE ADR	Pair Corr
0.78	ERNA	Eterna Therapeutics	Pair Corr
0.85	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.75	LLY	Eli Lilly Sell-off Trend	Pair Corr
0.74	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.81	PFE	Pfizer Inc Buyout Trend	Pair Corr
0.64	GNFT	Genfit	Pair Corr
0.68	SXTPW	60 Degrees Pharmaceu	Pair Corr
0.76	MRVI	Maravai Lifesciences	Pair Corr
0.67	NUVL	Nuvalent	Pair Corr
0.84	REGN	Regeneron Pharmaceuticals	Pair Corr
0.63	ABBV	AbbVie Inc	Pair Corr
0.74	AKAN	Akanda Corp	Pair Corr
0.82	AMGN	Amgen Inc	Pair Corr
0.71	ANRO	Alto Neuroscience,	Pair Corr
0.66	AQST	Aquestive Therapeutics Buyout Trend	Pair Corr
0.65	ARDX	Ardelyx	Pair Corr

Moving against CalciMedica, Stock

0.78	BMY	Bristol Myers Squibb	Pair Corr
0.76	GILD	Gilead Sciences	Pair Corr
0.74	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.62	DYAI	Dyadic International	Pair Corr
0.47	DNA	Ginkgo Bioworks Holdings	Pair Corr
0.66	ABCL	Abcellera Biologics	Pair Corr
0.65	MNMD	Mind Medicine	Pair Corr
0.35	MOLN	Molecular Partners	Pair Corr
0.85	TARS	Tarsus Pharmaceuticals	Pair Corr

Related Correlations Analysis

	DGII	LPCN	ASUR	PMNXF	MTX	LOMLF	PAYO
DGII		0.15	0.36	-0.26	0.87	-0.68	0.88	DGII
LPCN	0.15		0.05	0.49	0.02	0.17	0.04	LPCN
ASUR	0.36	0.05		0.24	0.33	-0.17	0.34	ASUR
PMNXF	-0.26	0.49	0.24		-0.26	0.61	-0.43	PMNXF
MTX	0.87	0.02	0.33	-0.26		-0.51	0.87	MTX
LOMLF	-0.68	0.17	-0.17	0.61	-0.51		-0.75	LOMLF
PAYO	0.88	0.04	0.34	-0.43	0.87	-0.75		PAYO
	DGII	LPCN	ASUR	PMNXF	MTX	LOMLF	PAYO

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

PAYO	+ 0.88	DGII
MTX	+ 0.87	DGII
PAYO	+ 0.87	MTX
LOMLF	+ 0.61	PMNXF
PMNXF	+ 0.49	LPCN
ASUR	+ 0.36	DGII

High negative correlations

PAYO	- 0.75	LOMLF
LOMLF	- 0.68	DGII
LOMLF	- 0.51	MTX
PAYO	- 0.43	PMNXF
MTX	- 0.26	PMNXF
PMNXF	- 0.26	DGII

Risk-Adjusted Indicators

There is a big difference between CalciMedica, Stock performing well and CalciMedica, Common Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CalciMedica, Common's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
DGII	1.43	0.24	0.19	0.19	1.26	(1.68)	3.54	(2.48)	12.64
LPCN	3.38	0.25	0.04	(1.62)	4.71	(3.34)	7.08	(6.20)	24.60
ASUR	1.95	(0.02)	0.00	0.05	3.13	(2.15)	5.27	(3.76)	19.48
PMNXF	1.92	0.01	0.00	0.07	2.88	(2.16)	3.95	(4.92)	16.43
MTX	1.27	0.02	0.05	0.07	1.29	(1.41)	2.46	(2.49)	11.90
LOMLF	2.14	(0.33)	0.00	0.91	0.00	0.00	4.76	(4.76)	15.00
PAYO	1.37	0.49	0.21	0.70	1.44	(1.53)	2.27	(2.46)	28.47

CalciMedica, Common Corporate Executives

Elected by the shareholders, the CalciMedica, Common's board of directors comprises two types of representatives: CalciMedica, Common inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CalciMedica,. The board's role is to monitor CalciMedica, Common's management team and ensure that shareholders' interests are well served. CalciMedica, Common's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CalciMedica, Common's outside directors are responsible for providing unbiased perspectives on the board's policies.

Kenneth Stauderman	CoFounder Officer	Profile
Stefan MD	CoFounder Advisor	Profile
Patrick Hogan	CoFounder Advisor	Profile
Anjana Rao	CoFounder Advisor	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC